The DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.
Drug delivery strategies for poorly water-soluble drugs
Abstract
The drug candidates coming from combinatorial chemistry research and/or the drugs selected from biologically based high-throughput screening are quite often very lipophilic, as these drug candidates exert their pharmacological action at or in biological membranes or membrane-associated proteins. This challenges drug delivery institutions in industry or academia to develop carrier systems for the optimal oral and parenteral administration of these drugs. To mention only a few of the challenges for this class of drugs: their oral bioavailability is poor and highly variable, and carrier development for parenteral administration is faced with problems, including the massive use of surface-active excipients for solubilisation. Formulation specialists are confronted with an even higher level of difficulties when these drugs have to be delivered site specifically. This article addresses the emerging formulation designs for delivering of poorly water-soluble drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
Solid lipid nanoparticles Production, characterization and applications
Mehnert, W. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00105-3 · Cited by 3,150
Improving drug solubility for oral delivery using solid dispersions
Leuner, C. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00076-x · Cited by 2,574
Pharmaceutical Applications of Cyclodextrins. 1. Drug Solubilization and Stabilization
Loftsson, T., & Brewster, M. E. (1996) · Journal of Pharmaceutical Sciences · doi:10.1021/js950534b · Cited by 2,176
Microemulsion-based media as novel drug delivery systems
Lawrence, M. J., & Rees, G. D. (2000) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00103-4 · Cited by 2,040
Pharmaceutical Applications of Solid Dispersion Systems
Chiou, W. L., & Riegelman, S. (1971) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600600902 · Cited by 1,799
Serajuddin, A. T. M. (1999) · Journal of Pharmaceutical Sciences · doi:10.1021/js980403l · Cited by 1,648
Nanosuspensions as particulate drug formulations in therapy
Müller, R. H., Jacobs, C., & Kayser, O. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00118-6 · Cited by 1,370
Pouton, C. W. (2006) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2006.04.016 · Cited by 1,293
Nanosizing: a formulation approach for poorly-water-soluble compounds
Merisko-Liversidge, E., Liversidge, G. G., & Cooper, E. R. (2003) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(02)00251-8 · Cited by 1,263
The mechanisms of drug release from solid dispersions in water-soluble polymers
Craig, D. Q. M. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00891-2 · Cited by 963
Pharmaceutical Applications of Cyclodextrins. 2. In Vivo Drug Delivery
Rajewski, R. A., & Stella, V. J. (1996) · Journal of Pharmaceutical Sciences · doi:10.1021/js960075u · Cited by 824
Muller, R. H., & Keck, C. M. (2004) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2004.06.007 · Cited by 819
Cyclodextrins in drug delivery
Loftsson, T., Jarho, P., Másson, M., & Järvinen, T. (2005) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2.1.335 · Cited by 793
Löbenberg, R. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00091-6 · Cited by 729
Cyclodextrins: Their Future in Drug Formulation and Delivery
Stella, V. J., & Rajewski, R. A. (1997) · Pharmaceutical Research · doi:10.1023/a:1012136608249 · Cited by 697
Freitas, C., & Müller, R. H. (1998) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(98)00092-1 · Cited by 687
Lipid-based vehicles for the oral delivery of poorly water soluble drugs
Humberstone, A. J., & Charman, W. N. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00494-2 · Cited by 577
Biopharmaceutics Classification System: The Scientific Basis for Biowaiver Extensions
Yu, L. X., Amidon, G. L., Polli, J. E., Zhao, H., Mehta, M. U., Conner, D. P., Shah, V. P., Lesko, L. J., Chen, M.-L., Lee, V. H. L., et al. (2002) · Pharmaceutical Research · doi:10.1023/a:1016473601633 · Cited by 571
Kang, B. K., Lee, J. S., Chon, S. K., Jeong, S. Y., Yuk, S. H., Khang, G., Lee, H. B., & Cho, S. H. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2003.12.028 · Cited by 545
Vitamin A-loaded solid lipid nanoparticles for topical use: drug release properties
Jenning, V., Schäfer-Korting, M., & Gohla, S. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00223-0 · Cited by 545
Highly soluble cyclodextrin derivatives: chemistry, properties, and trends in development
Szente, L. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00092-1 · Cited by 540
The role of solid nanoparticle technology in the parenteral delivery of poorly water-soluble drugs
KIPP, J. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.07.019 · Cited by 529
Freitas, C., & Müller, R. H. (1999) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(98)00074-5 · Cited by 483
Yang, S. C., Lu, L. F., Cai, Y., Zhu, J. B., Liang, B. W., & Yang, C. Z. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00007-3 · Cited by 476
Lipid Formulations of Amphotericin B: Clinical Efficacy and Toxicities
Wong-Beringer, A., Jacobs, R. A., & Guglielmo, B. J. (1998) · Clinical Infectious Diseases · doi:10.1086/514704 · Cited by 395
Solid lipid nanoparticles for enhancing vinpocetine's oral bioavailability
Luo, Y., Chen, D., Ren, L., Zhao, X., & Qin, J. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.05.010 · Cited by 395
In vitro assessment of oral lipid based formulations
Porter, C. J. H., & Charman, W. N. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00182-x · Cited by 389
Mohammed, A. R., Weston, N., Coombes, A. G. A., Fitzgerald, M., & Perrie, Y. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.07.010 · Cited by 386
Body Distribution of Camptothecin Solid Lipid Nanoparticles After Oral Administration
Yang, S., Zhu, J., Lu, Y., Liang, B., & Yang, C. (1999) · Pharmaceutical Research · doi:10.1023/a:1018888927852 · Cited by 324
Oral bioavailability of cyclosporine: Solid lipid nanoparticles (SLN®) versus drug nanocrystals
Müller, R. H., Runge, S., Ravelli, V., Mehnert, W., Thünemann, A. F., & Souto, E. B. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.02.045 · Cited by 304
Liversidge, G. G., & Conzentino, P. (1995) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(95)00148-c · Cited by 294
Ball, P. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/49.1.31 · Cited by 290
Pharmaceutical profiling in drug discovery
Kerns, E. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02649-7 · Cited by 288
Gabizón, A., Dagan, A., Goren, D., Barenholz, Y., & FUKS, Z. Y. (1982) · PubMed · Cited by 263
Overview of the lipid formulations of amphotericin B
Dupont, B. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/49.suppl_1.31 · Cited by 260
Organized surfactant systems: microemulsions
Shinoda, K., & Lindman, B. (1987) · Langmuir · doi:10.1021/la00074a001 · Cited by 252
Verreck, G., Six, K., Van den Mooter, G., Baert, L., Peeters, J., & Brewster, M. E. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00591-4 · Cited by 250
Müller, R. (1996) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(96)04539-5 · Cited by 242
Merisko-Liversidge, E., Sarpotdar, P., Bruno, J., Hajj, S., Wei, L., Peltier, N., Rake, J., Shaw, J. M., Pugh, S., Polin, L., et al. (1996) · Pharmaceutical Research · doi:10.1023/a:1016051316815 · Cited by 230
Peters, K. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/45.1.77 · Cited by 228
Lipids, Lipophilic Drugs, and Oral Drug Delivery—Some Emerging Concepts
Charman, W. N. (2000) · Journal of Pharmaceutical Sciences · doi:10.1002/1520-6017(200008)89:8<967::aid-jps1>3.0.co;2-r · Cited by 224
Müller, R., Maaben, S., Weyhers, H., & Mehnert, W. (1996) · Journal of Drug Targeting · doi:10.3109/10611869609015973 · Cited by 222
Effect of combined use of nonionic surfactant on formation of oil-in-water microemulsions
Li, P., Ghosh, A., Wagner, R. F., Krill, S., Joshi, Y. M., & Serajuddin, A. T. M. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.08.024 · Cited by 216
Gao, Z.-G., Choi, H.-G., Shin, H.-J., Park, K.-M., Lim, S.-J., Hwang, K.-J., & Kim, C.-K. (1998) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(97)00325-6 · Cited by 207
Tetko, I. V., & Bruneau, P. (2004) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20217 · Cited by 206
Fahr, A., Hoogevest, P. V., May, S., Bergstrand, N., & S. Leigh, M. L. (2005) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.05.012 · Cited by 189
Self-citationFormulation of amphotericin B as nanosuspension for oral administration
Kayser, O. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00686-5 · Cited by 186
Jores, K., Mehnert, W., & Mäder, K. (2003) · Pharmaceutical Research · doi:10.1023/a:1025065418309 · Cited by 185
Characterization, toxicity and therapeutic efficacy of adrïamycin encapsulated in liposomes
Olson, F., Mayhew, E., Maslow, D., Rustum, Y., & Szoka, F. (1982) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(82)90060-8 · Cited by 179
Incorporation of cyclosporin A in solid lipid nanoparticles (SLN)
Ugazio, E., Cavalli, R., & Gasco, M. R. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00268-5 · Cited by 168
Cyclodextrins and carrier systems
Duchêne, D., Wouessidjewe, D., & Ponchel, G. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00046-2 · Cited by 159
Emulsions containing partially water-miscible solvents for the preparation of drug nanosuspensions
Trotta, M., Gallarate, M., Pattarino, F., & Morel, S. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00432-1 · Cited by 152
Dollo, G., Corre, P. L., Guérin, A., Chevanne, F., Burgot, J. L., & Verge, R. L. (2003) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(03)00134-9 · Cited by 148
Production of solid lipid nanoparticles (SLN): scaling up feasibilities
Dingler, A., & Gohla, S. (2002) · Journal of Microencapsulation · doi:10.1080/02652040010018056 · Cited by 143
Advances in the Use of Tocols as Drug Delivery Vehicles
Constantinides, P. P., Han, J., & Davis, S. S. (2006) · Pharmaceutical Research · doi:10.1007/s11095-005-9262-9 · Cited by 138
Tocol emulsions for drug solubilization and parenteral delivery
Constantinides, P. P., Tustian, A. K., & Kessler, D. R. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.12.005 · Cited by 135
Becket, G., Schep, L. J., & Tan, M. Y. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(98)00382-2 · Cited by 133
Formulation Development and Antitumor Activity of a Filter-Sterilizable Emulsion of Paclitaxel
Constantinides, P. P., Lambert, K. J., Tustian, A. K., Schneider, B., Lalji, S., Ma, W., Wentzel, B., Kessler, D. R., Worah, D. M., & Quay, S. C. (2000) · Pharmaceutical Research · doi:10.1023/a:1007565230130 · Cited by 130
Itraconazole in Cyclodextrin Solution
Stevens, D. A. (1999) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.19.8.603.31529 · Cited by 129
Triglyceride-Based Microemulsion for Intravenous Administration of Sparingly Soluble Substances
von Corswant, C., Thorén, P., & Engström, S. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js970258w · Cited by 120
Carrigan, P. J., & Bates, T. R. (1973) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600620918 · Cited by 116
Formulation and biological evaluation of glimepiride–cyclodextrin–polymer systems
Ammar, H. O., Ha, S., Ghorab, M., & Mahmoud, A. A. K. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.11.024 · Cited by 106
Araya, H., Tomita, M., & Hayashi, M. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.08.022 · Cited by 104
Hydrosols : alternatives for the parenteral application of poorly water soluble drugs
Gassmann, P., List, M., Schweitzer, A., & Sucker, H. (1994) · European Journal of Pharmaceutics and Biopharmaceutics · Cited by 103
Process characteristics and compaction of spray-dried emulsions containing a drug dissolved in lipid
Hansen, T., Holm, P., & Schultz, K. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.08.014 · Cited by 79
Westesen, K. (2000) · Colloid & Polymer Science · doi:10.1007/s003969900257 · Cited by 79
Scaling up feasibility of the production of solid lipid nanoparticles (SLN).
Gohla, S., & Dingler, A. (2001) · PubMed · Cited by 78
Bates, T. R., & Sequeira, J. (1975) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600640513 · Cited by 76
Moghimi, S. M. (2006) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152006778699130 · Cited by 76
McCormack, B., & Gregoriadis, G. (1998) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(97)00413-4 · Cited by 74
Itraconazole Formulation Studies of the Melt-Extrusion Process with Mixture Design
Rambali, B., Verreck, G., Baert, L., & Massart, D. L. (2003) · Drug Development and Industrial Pharmacy · doi:10.1081/ddc-120021313 · Cited by 74
Formulation andin vitro-in vivoevaluation of piribedil solid lipid micro- and nanoparticles
Demirel, Y. Y. M. (2001) · Journal of Microencapsulation · doi:10.1080/02652040010018119 · Cited by 74
Nanosuspensions as the most promising approach in nanoparticulate drug delivery systems.
Rao, G. C. S., Kumar, M. S., Mathivanan, N., & Rao, M. E. B. (2004) · PubMed · Cited by 71
Kushida, I., Ichikawa, M., & Asakawa, N. (2002) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10020 · Cited by 69
Ammar, H. O., Ha, S., Ghorab, M., & Mahmoud, A. A. K. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.04.002 · Cited by 67
Debuigne, F., Cuisenaire, J., Jeunieau, L., Masereel, B., & Nagy, J. B. (2001) · Journal of Colloid and Interface Science · doi:10.1006/jcis.2001.7879 · Cited by 65
Preparation, Characterization, and Biological Analysis of Liposomal Formulations of Vincristine
Waterhouse, D., Madden, T. D., Cullis, P. R., Bally, M. B., Mayer, L. D., & Webb, M. S. (2005) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(05)91002-1 · Cited by 63
Üner, M., Wissing, S. A., Yener, G., & Müller, R. H. (2005) · PubMed · Cited by 60
Improvement of some pharmaceutical properties of DY-9760e by sulfobutyl ether β-cyclodextrin
Nagase, Y., Hirata, M., Wada, K., Arima, H., Hirayama, F., Irie, T., Kikuchi, M., & Uekama, K. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00851-1 · Cited by 60
Bioavailability of phenytoin in lipid containing dosage forms in rats
Chakrabarti, S., & Belpaire, F. M. (1978) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1978.tb13247.x · Cited by 52
Schote, U., Ganz, P., Fahr, A., et al. (2002) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10071 · Cited by 48
Self-citationHansen, T., Holm, P., Rohde, M., & Schultz, K. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.01.003 · Cited by 44
Iwanaga, K., Kushibiki, T., Miyazaki, M., & Kakemi, M. (2006) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.29.508 · Cited by 38
Liposomal Formulations of Cyclosporin A: Influence of Lipid Type and Dose on Pharmacokinetics
Fahr, A., Holz, M., & Fricker, G. (1995) · Pharmaceutical Research · doi:10.1023/a:1016220211925 · Cited by 37
Self-citationChemical Modification of Triamcinolone Acetonide toImprove Liposomal Encapsulation
Goundalkar, A., & Mezei, M. (1984) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600730634 · Cited by 26
Seelig, J., & Fahr, A. (2001) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v18.i2.10 · Cited by 25
Self-citationPanini, R., Vandelli, M. A., Forni, F., Pradelli, J. M., & Salvioli, G. (1995) · Pharmacological Research · doi:10.1016/1043-6618(95)80019-0 · Cited by 23
Cited by
Solubility Advantage of Amorphous Drugs and Pharmaceutical Cocrystals
Babu, N. J., & Nangia, A. (2011) · Crystal Growth & Design · doi:10.1021/cg200492w · Cited by 1,004
Khadka, P., Ro, J., Kim, H., Kim, I., Kim, J. T., Kim, H., Cho, J. M., Yun, G., & Lee, J. (2014) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2014.05.005 · Cited by 998
Baghel, S., Cathcart, H., & O'Reilly, N. J. (2016) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2015.10.008 · Cited by 970
Use of surfactants for the remediation of contaminated soils: A review
Mao, X., Jiang, R., Xiao, W., & Yu, J. (2015) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2014.12.009 · Cited by 811
Fuhrmann, G., Serio, A., Mazo, M., Nair, R., & Stevens, M. M. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.11.029 · Cited by 742
Metadata
- Authors
- Fahr, A., & Liu, X.
- Venue
- Expert Opinion on Drug Delivery
- Publisher
- Informa Healthcare
- Published
- 2007-07
- Volume
- 4
- Issue
- 4
- Pages
- 403-416
- ISSN
- 1742-5247 (ISSN-L)
- 1744-7593
- OpenAlex
- W2113883162
- Cited by
- 568
- References
- 88
- FWCI
- 7.10
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.